← Back to headlines
Xeris Pharmaceuticals Q2 2026 Earnings Preview and BioCryst Pharmaceuticals Summary
This report includes a preview of Xeris Pharmaceuticals' Q2 2026 earnings and a summary of BioCryst Pharmaceuticals, Inc.'s Q2 2026 earnings call. Investors are anticipating financial updates from both companies.
5 Aug, 16:50 — 5 Aug, 16:50
Sources
Showing 1 of 2 sources
Coverage Timeline
First report: Yahoo · 5 Aug, 16:50|Full coverage: 2 · 28m|Window: 28m
Left-leaningCenterRight-leaning
